Satoshi Yasuda

aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis

Rong Fan, George Papatheodoridis, Jian Sun et al. · Journal of Hepatology · 2020 · 349 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis

Jan Best, Lars P. Bechmann, Jan‐Peter Sowa et al. · Clinical Gastroenterology and Hepatology · 2019 · 289 citations

Medicine, Oncology, Pathology +17

Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: A propensity score analysis

Takashi Kumada, Hidenori Toyoda, Toshifumi Tada et al. · Journal of Hepatology · 2012 · 139 citations

Medicine, Oncology, Carcinogenesis +14

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis

Margherita Rimini, Lorenza Rimassa, Kazuomi Ueshima et al. · ESMO Open · 2022 · 130 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +14

Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population

Andrea Casadei‐Gardini, Margherita Rimini, Toshifumi Tada et al. · European Journal of Cancer · 2022 · 129 citations · Full text

Medicine, Oncology, Pharmacology +15